Showing results (291-300 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort StudyKaren M Clements, Robin E Clark, Pavel Lavitas, et al.Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Medication Reconciliation in Oncological Patients: A Randomized Clinical TrialTriana González-Carrascosa Vega, Jesús Francisco Sierra-Sánchez, María José Martínez-Bautista, et al.Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims AnalysisMeredith Y Smith, Meritxell Sabidó-Espin, Anton Trochanov, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2015
Patient Outcomes in a Medicaid Managed Care Lock-In ProgramTheresa R F Dreyer, Thomas Michalski, Brent C WilliamsJournal of Managed Care & Specialty Pharmacy|December 3, 2014
Geospatial analysis of statin adherence using pharmacy claims data in the state of MichiganSteven R Erickson, Yuan-Nung Tony LinJournal of Managed Care & Specialty Pharmacy|December 3, 2014
Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in SpainZeneida Perseguer-Torregrosa, Domingo Orozco-Beltrán, Vicente F Gil-Guillen, et al.Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Impact of specialty pharmacy on telaprevir-containing 3-drug hepatitis C regimen persistenceRochelle R Henderson, Jay Visaria, Gail G Bridges, et al.Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Impact of an intravenous trimethoprim/sulfamethoxazole shortage on treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumoniaThomas J Dilworth, Omar M Ibrahim, Renée-Claude MercierJournal of Managed Care & Specialty Pharmacy|October 30, 2014
Do value thresholds for oncology drugs differ from nononcology drugs?Yuna Hyo Jung Bae, C Daniel MullinsJournal of Managed Care & Specialty Pharmacy|October 30, 2014
A case study in generic drug use: should there be risk adjustment in incentive payments for the use of generic medications?Surrey M Walton, Christine Rash, Bruce L Lambert, et al.Pageof 185